NDC 17433-9877-01 - ENEMEEZ Plus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17433-9877
- Requested NDC
- 17433-9877-01
- Package NDCs from labels
- 17433-9877-0, 17433-9877-3, 17433-9877-6, 17433-9877-5, 17433-9877-7, 17433-9877-2, 17433-9877-1, 17433-9877-4, 17433-9877-01
- Manufacturer
- Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals
- Effective date
- 2026-06-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ENEMEEZ Plus - Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals | Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals | 2026-06-30 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17433-9877-0 | ENEMEEZ Plus | 5 mL in 1 TUBE | LIQUID | 5 | 22 | |
| 17433-9877-1 | ENEMEEZ Plus | 1 in 1 CONTAINER | LIQUID | 1 | 22 | |
| 17433-9877-2 | ENEMEEZ Plus | 2 in 1 CONTAINER | LIQUID | 2 | 22 | |
| 17433-9877-3 | ENEMEEZ Plus | 30 in 1 CONTAINER | LIQUID | 30 | 22 | |
| 17433-9877-5 | ENEMEEZ Plus | 5 in 1 CONTAINER | LIQUID | 5 | 22 | |
| 17433-9877-6 | ENEMEEZ Plus | 35 in 1 CONTAINER | LIQUID | 35 | 22 | |
| 17433-9877-7 | ENEMEEZ Plus | 6 in 1 CONTAINER | LIQUID | 6 | 22 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17433-9877 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [QUEST PRODUCTS, LLC] | 20 | Current NDC, Legacy NDC, 7 package rows | 20250216_1670ca59-7275-4ac6-bef4-674a7b24c7b3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17433-9877-0 | ML - Milliliter | 17433-9877 | 2e9b0ac6-919d-4fe2-a8ba-a2b8c95ed351 | 1 | 2018-05-09 |
| 17433-9877-2 | ML - Milliliter | 17433-9877 | 0f3c3df0-f564-4e9a-9b9e-7083e97ea8fe | 1 | 2025-09-12 |
| 17433-9877-3 | ML - Milliliter | 17433-9877 | 53354c2d-cba7-4902-8a17-9cd8f7ede81b | 1 | 2013-02-13 |
| 17433-9877-5 | ML - Milliliter | 17433-9877 | 7b0c7f3e-bcf2-4dd1-b6d2-bb54d55b0209 | 1 | 2022-05-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BENZOCAINE | ACTIVE INGREDIENT | U3RSY48JW5 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| BENZOCAINE | ACTIVE MOIETY | U3RSY48JW5 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens Eye Drops Maximum Redness Relief 15mL | GLYCERIN, NAPHAZOLINE HCI | Walgreen Company | 949d4a4d-b0f8-81f8-e053-2995a90a818d | 2023-12-20 | Warnings | PDC6A3C0OX |
| Walgreens Redness Relief Eye Drops 15mL | GLYCERIN, NAPHAZOLINE HCI | Walgreen Company | 94a0d08a-a6db-1088-e053-2995a90ab4fd | 2023-12-20 | Warnings | PDC6A3C0OX |
| Target Eye Drops Maximum Redness Relief Eye | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Target Corporation | 1b26cd3b-4a05-4623-b320-01f22b3106ff | 2023-12-20 | Warnings | PDC6A3C0OX |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | PDC6A3C0OX |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | PDC6A3C0OX |
| Topcare Maximum Redness Relief Eye Drops | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Topco Assoc LLC | 9c6193a6-d824-1b27-e053-2995a90ab3cf | 2023-12-20 | Warnings | PDC6A3C0OX |
| Top Care Castor Oil | CASTOR OIL | TOPCO ASSOCIATES LLC | 8dce1a1f-e765-9c75-e053-2995a90abf9f | 2023-12-18 | Warnings | M007 |
| DermaWound Wound Care Venous Stasis | BENZOCAINE HYDROCHLORIDE | Progressive Doctors, LLC | 6221ba86-8b7f-48c8-8284-6950f9fc36b1 | 2023-12-15 | Warnings | U3RSY48JW5 |
| Cleareyes Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Lil' Drug Store Products, Inc. | 39e4ab2b-ae12-4339-b219-109cf0f7f06a | 2023-12-15 | Warnings | PDC6A3C0OX |
| Humco Epson Salt | MAGNESIUM SULFATE | Humco Holding Group, Inc. | 7a9d1b77-6c39-46f1-86f2-4059dde20f85 | 2023-12-15 | Warnings | M007 |
| Humco Mineral Oil Heavy | MINERAL OIL | Humco Holding Group, Inc. | 9f943fdf-5058-4e18-ba96-6be112bf72ca | 2023-12-15 | Warnings | M007 |
| Rite Aid Castor Oil | CASTOR OIL | Rite Aid Corporation. | 5e0d3664-b01b-ba28-e053-2991aa0a8a4c | 2023-12-15 | Warnings | M007 |
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | PDC6A3C0OX |
| GNP Castor Oil | CASTOR OIL | Amerisource Bergen | 5d06bec6-f1e7-4f0c-e053-2991aa0a8ad8 | 2023-12-14 | Warnings | M007 |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 Skin Protectant | GLYCERIN | L'Oreal USA Products Inc | 32eaaaab-41bd-4efe-a71d-92e3a702c1e5 | 2023-12-11 | Warnings | PDC6A3C0OX |
| La Roche Posay Laboratoire Dermatologique Cicaplast Defense B5 | GLYCERIN | Cosmetique Active Production | 01c8a0d5-bcd1-4639-be45-530a226401f0 | 2023-12-11 | Warnings | PDC6A3C0OX |
| Gelato Topical Anesthetic | BENZOCAINE | Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc | 0070858b-e02e-431f-a7c2-313fef01791b | 2023-12-07 | Warnings | U3RSY48JW5 |
| Gelato Topical Anesthetic | BENZOCAINE | Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc | d1802f08-80cb-41dd-b34d-9c576b101ddb | 2023-12-07 | Warnings | U3RSY48JW5 |
| Gelato Topical Anesthetic | BENZOCAINE | Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc | 80182c43-100f-4b15-a07e-819599ab9562 | 2023-12-07 | Warnings | U3RSY48JW5 |
| Gelato Topical Anesthetic | BENZOCAINE | Mycone Dental Supply Co., Inc DBA Keystone Industries and Deepak Products Inc | c19e6426-8f1e-47b3-a3a6-551a5bec6cd9 | 2023-12-07 | Warnings | U3RSY48JW5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.